The pharmaceutical industry is aggressively evolving, with growing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To meet https://techonpage.com/story5898779/prominent-us-based-dulaglutide-api-manufacturing-services